Income Statement
MIND MEDICINE (MINDMED) INC.
DFTX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
166.31 | 103.92 | 93.87 | 66.33 | 93.85 |
|
Research & Development
|
117.70 | 65.30 | 52.12 | 36.17 | 34.79 |
|
Selling, General & Administrative
|
48.64 | 38.62 | 41.74 | 30.16 | 59.07 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-166.31 | -103.92 | -93.87 | -66.33 | -93.85 |
|
Non-Operating Income
|
- | - | - | -9.54 | 0.34 |
|
Interest Income
|
10.96 | 11.56 | - | - | - |
|
Interest Expense
|
5.50 | 2.30 | 0.70 | - | - |
|
Other Non-Op Income / Expense
|
-17.48 | -4.76 | -1.87 | 9.54 | -0.34 |
|
Income Before Tax
|
-183.79 | -108.68 | -95.73 | -56.80 | -94.19 |
|
Income Tax Expense
|
- | - | - | 0.00 | -1.16 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-183.79 | -108.68 | -95.73 | -56.80 | -93.04 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-166.31 | -103.92 | -93.87 | -66.33 | -93.85 |
|
Earnings Per Share (Basic)
|
-2.06 | -1.54 | -2.44 | -1.84 | - |
|
Diluted EPS
|
-2.06 | -1.54 | -2.44 | -1.84 | - |
|
Weighted Average Shares
|
89.33 | 70.46 | 39.16 | 30.86 | - |
|
Diluted Weighted Avg Shares
|
89.33 | 70.46 | 39.16 | 30.86 | - |
|
Comprehensive Income
|
0.27 | 0.48 | -0.28 | -0.42 | 0.76 |